BREAST CANCER - ER+, HER2-, PIK3CA GENE MUTATION

Clinical trials for BREAST CANCER - ER+, HER2-, PIK3CA GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new BREAST CANCER - ER+, HER2-, PIK3CA GENE MUTATION trials appear

Sign up with your email to follow new studies for BREAST CANCER - ER+, HER2-, PIK3CA GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Scientists hunt for clues in old cancer samples to predict treatment failure

Knowledge-focused Not yet recruiting

This study aims to understand why some breast cancers stop responding to standard hormone therapy. Researchers will analyze stored tumor tissue from 70 patients who previously received treatment, looking for specific protein patterns. The goal is to find markers that might predic…

Matched conditions: BREAST CANCER - ER+, HER2-, PIK3CA GENE MUTATION

Sponsor: Assiut University • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:42 UTC

BREAST CANCER - ER+, HER2-, PIK3CA GENE MUTATION

Get alerted when new BREAST CANCER - ER+, HER2-, PIK3CA GENE MUTATION trials appear

Scientists hunt for clues in old cancer samples to predict treatment failure